Translational Clinical Research in Major Eye Diseases (TCR-Eye)

主要眼病转化临床研究（TCR-Eye）

• 批准号: nhmrc : 529923
• 负责人: A/Pr Ecosse Lamoureux
• 金额: $ 170.19万
• 依托单位: Centre for Eye Research Australia Ltd
• 依托单位国家: 澳大利亚
• 项目类别: Centre for Research Excellence
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/translational-clinical-research-tcr-eye/94636
• 关键词: Translational; Clinical; Research; Major; Eye

The four eye diseases that cause the majority of vision loss in Australia, age-related macular degeneration, diabetic retinopathy, cataract and glaucoma, impose a significant socio-economic burden, costing our nation -$lo billion a year. This CCRE will fund a world leading, broad-based, clinical and translational research program in Melbourne and Sydney to tackle these eye diseases. The new knowledge and innovative clinical strategies developed in this CCRE will impact on clinical ophthalmology and the practice of other medical disciplines.

导致澳大利亚大部分视力丧失的四种眼病，即年龄相关性黄斑变性、糖尿病视网膜病变、白内障和青光眼，造成了重大的社会经济负担，每年给我们国家造成100亿美元的损失。该CCRE将在墨尔本和悉尼资助一个世界领先的、基础广泛的临床和转化研究项目，以解决这些眼科疾病。该CCRE中开发的新知识和创新临床策略将对临床眼科学和其他医学学科的实践产生影响。